-
Je něco špatně v tomto záznamu ?
Obesity and Dyslipidemia
B. Nussbaumerova, H. Rosolova
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- dieta MeSH
- dyslipidemie * komplikace MeSH
- HDL-cholesterol MeSH
- hmotnostní úbytek MeSH
- LDL-cholesterol MeSH
- lidé MeSH
- lipoproteiny MeSH
- obezita * komplikace epidemiologie MeSH
- triglyceridy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
PURPOSE OF REVIEW: This article sumarizes pathopysiological consequencies between obesity and dyslipidemia and aims to bring some practical approach. RECENT FINDINGS: Dyslipidemia is often present in individuals with obesity and simultaneusly, many obese individuals have lipid metabolism disorders. Especially the abdominal obesity increases the cardiometabolic risk because of the presence of atherogenic dyslipidemia while the total low density lipoprotein cholesterol (LDL-C) may be normal. LDL-C is the primary goal in dyslipidemia treatment. Apoliprotein B (Apo B) and non - high density lipoprotein cholesterol (non-HDL-C) should be estimated to precise the cardiovascular risk and represents the secondary goal in treatment. Weight loss either with diet or antiobestic medication induces the decrease in triglycerides (TG) and LDL-C and the increase in HDL-C. Composition of nutrients, esp. fatty acids, influences lipid levels. Bariatric surgery is efficient in weight loss and has a significant effect on serum lipids. Dyslipidemia and obesity present common diseases that must be managed to decrease the cardiovascular risk and the risk of obesity-related complications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007886
- 003
- CZ-PrNML
- 005
- 20240423160347.0
- 007
- ta
- 008
- 240412s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11883-023-01167-2 $2 doi
- 035 __
- $a (PubMed)37979064
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nussbaumerova, Barbora $u 2nd Medical Department, Chales University, Faculty of Medicine in Pilsen, alej Svobody 76, Plzen (Pilsen), 323 00, Czech Republic. nussbaumerova@fnplzen.cz $1 https://orcid.org/0009000725269806
- 245 10
- $a Obesity and Dyslipidemia / $c B. Nussbaumerova, H. Rosolova
- 520 9_
- $a PURPOSE OF REVIEW: This article sumarizes pathopysiological consequencies between obesity and dyslipidemia and aims to bring some practical approach. RECENT FINDINGS: Dyslipidemia is often present in individuals with obesity and simultaneusly, many obese individuals have lipid metabolism disorders. Especially the abdominal obesity increases the cardiometabolic risk because of the presence of atherogenic dyslipidemia while the total low density lipoprotein cholesterol (LDL-C) may be normal. LDL-C is the primary goal in dyslipidemia treatment. Apoliprotein B (Apo B) and non - high density lipoprotein cholesterol (non-HDL-C) should be estimated to precise the cardiovascular risk and represents the secondary goal in treatment. Weight loss either with diet or antiobestic medication induces the decrease in triglycerides (TG) and LDL-C and the increase in HDL-C. Composition of nutrients, esp. fatty acids, influences lipid levels. Bariatric surgery is efficient in weight loss and has a significant effect on serum lipids. Dyslipidemia and obesity present common diseases that must be managed to decrease the cardiovascular risk and the risk of obesity-related complications.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a LDL-cholesterol $7 D008078
- 650 12
- $a obezita $x komplikace $x epidemiologie $7 D009765
- 650 12
- $a dyslipidemie $x komplikace $7 D050171
- 650 _2
- $a dieta $7 D004032
- 650 _2
- $a triglyceridy $7 D014280
- 650 _2
- $a lipoproteiny $7 D008074
- 650 _2
- $a hmotnostní úbytek $7 D015431
- 650 _2
- $a HDL-cholesterol $7 D008076
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rosolova, Hana $u 2nd Medical Department, Chales University, Faculty of Medicine in Pilsen, alej Svobody 76, Plzen (Pilsen), 323 00, Czech Republic $1 https://orcid.org/0000000292605482
- 773 0_
- $w MED00186151 $t Current atherosclerosis reports $x 1534-6242 $g Roč. 25, č. 12 (2023), s. 947-955
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37979064 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160344 $b ABA008
- 999 __
- $a ok $b bmc $g 2081725 $s 1217653
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 25 $c 12 $d 947-955 $e 20231118 $i 1534-6242 $m Current atherosclerosis reports $n Curr Atheroscler Rep $x MED00186151
- LZP __
- $a Pubmed-20240412
